Pharma's new top lobbyist is former Majority Leader Eric Cantor
Former House majority leader Eric Cantor jumps to the top of pharma lobbying as PhRMA’s new CEO, turning Capitol experience into industry muscle.
2 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 2 separate news trends connected to Ceo Appointment, spanning August 27, 2026 through September 29, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 18 article observations and 17 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Former House majority leader Eric Cantor jumps to the top of pharma lobbying as PhRMA’s new CEO, turning Capitol experience into industry muscle.
Gap's shares surge 12% after the company appoints a new CEO for its struggling Old Navy brand